Procalcitonin and C-reactive protein in differantiating to contamination from bacteremia

Brazilian Journal of Microbiology

Volumn 45, Issue 4, 2014, Pages 1415-1421

  Oksuz, Lutfiye ^a   Somer, Ayper ^a   Salman, Nuran ^a   Erk, Osman ^a   Gurler, Nezahat ^a  

^a Department of Medical Microbiology ^*  (Turkey)

Author keywords

Bacteremia; Blood cultures; C reactive protein; Contamination; Procalcitonin

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

BACTEREMIA; BLOOD; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; HUMAN; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC;

BACTEREMIA; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROTEIN PRECURSORS; ROC CURVE;

EID: 84923701274     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822014000400036     Document Type: Article

References (34)

1. Al-Nawas B, Krammer I, Shah PM (1996) Procalcitonin in diagnosis of severe infections. Eur J Med Res 1:331-333.
2. Baron EJ (coord ed) (2005) Blood Cultures, Cumulative Techniques and Procedures in Clinical Microbiology (Cumitech), ASM Press, Washington, D.C.
3. Becker KL, Snider R, Nylen ES (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations; Crit Care Med 36:941-952.
4. Bouadma L, Luyt CE, Tubach F et al. (2010) Use of procalcitonin to educe patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375:463-474.
5. Bossink AW, Groeneveld AB, Thijs LG (1999) Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1- antitrypsin and lactoferrin compared with clinical variables. Clin Infect Dis 29:398-407.
6. Clinical and Laboratory Standarts Institute (2007) Principles and Procedures for Blood Cultures. Approved Guideline. M47-A, Vol. 27 No. 17.
7. Wayne, PA. Clinical Laboratory Standards Institute (2011) Performance Standards for Antimicrobial Suscebtibility Testing. 21st Informational Supplement. M100-S21, Vol. 31, No. 1.
8. Wayne, PA. Cohen J, Brun-Buisson C, Torres A, Jorgensen J (2004) Diagnosis of infection in sepsis: An evidence bases review. Crit Care Med 32 Suppl (11):S466-494.
9. de Beer FC, Shine B, Pepys M (1982) Radiometric ligand binding assay for C-reactive protein. Complexed C-reactive protein is not detectable in acute phase serum. Clin Exp Immunol 50:231-237.
10. de Bont ES, Vellenga E, Swaanenburg J, Kamps W (2000) Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever? Infection 28:398-400.
11. Engel A, Steinbach G, Kern P, Kern WV (1999) Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 31:185-189.
12. Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U (2000) Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 111:1093-1102.
13. Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H (2001) Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 32:1718-1725.
14. Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P, Galani L, Anagnostopoulos N, Grecka P, Lubos D, Aoun M, Athanassiou K, Bouza E, Devigili E, Krcmery V, Menichetti F, Panaretou E, Papageorgiou E, Plachouras D (2004) Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect 10:628-633.
15. Hall KK, Lyman JA (2006) Update review of blood culture contamination. Clin Microb Rev 19:788-802.
16. Jeong S, Park Y, Cho Y, Kim HS (2012) Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture. Clin Chim Acta 413:1731-1736.
17. Jimeno A, Garcia-Velasco A, del Val O, Gonzalez-Billalabeitia E, Hernando S, Hernandez R, Sanchez-Munoz A, Lopez-Martin A, Duran I, Robles L, Cortes-Funes H, Paz-Ares L (2004) Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 100:2462-2469.
18. Kim MH, Lim G, Kang SY, Lee WI, Suh JT, Lee HJ (2011) Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever. Yonsei Med J 52:276-281.
19. Kristoffersen KB, Sogaard OS, Wejse C, Black FT et al. (2009) Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission-a randomized trial. Clin Microbiol Infect 15:481-487.
20. Llewelyn M, Cohen J (2001) Diagnosis of infection in sepsis. Intensive Care Med 27 (Suppl 1):S10-S32.
21. Meisner M (2000) Procalcitonin: A new, innovative infection parameter. Biochemical and clinical aspects. Georg Thieme Verlag, Stutgard Newyork.
22. Pepys MB, Hirschfield GM (2003) C-rective protein: a critical update. J Clin Invest 111:1805-1812.
23. Pihusch M, Pihusch R, Fraunberger P et al. (2006) Evaluation of C-reactive protein, interlekin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients. Eur J Haematol 76:93-101.
24. Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM (2011) Procalcitonin as a Marker for the Detection of Bacteremia and Sepsis in the Emergency Department. AmJ Clin Pathol 135:182-189.
25. Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K (2008) The role of procalcitonin in febrile neutropenic patients: Review of the literature. Infection 36:396-406.
26. Schuetz P, Mueller B, Trampuz A (2007) Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection 35:352-355.
27. Schuetz P, Albrich W, Mueller B (2011) Procalsitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 9:107.
28. Schuttrumpf S, Binder L, Hagemann T, Berkovic D, Trumper L, Binder C (2006) Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations. Clin Infect Dis 43:468-473.
29. Secmeer G, Devrim I, Kara A, Ceyhan M, Cengiz B, Kutluk T, Buyukpamukcu M, Yetgin S, Tuncer M, Uludag AK, Tezer H, Yildirim I (2007) Role of Procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol 29:107-111.
30. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Metaanalysis. Clin Infect Dis 39:206-217.
31. Svaldi M, Hirber J, Lanthaler AI, Mayr O, Faes S, Peer E, Mitterer M (2001) Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 115:53-57.
32. van Rossum AMC, Wulkan RW, Murphy AMO (2004) Procalcitonin as an early marker of infection in neonates and children. Lancet Inf Dis 4:620-630.
33. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, Schmidt-Wolf IG, Marklein G, Schroeder S, Stuber F (2004) Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 23:539-544.
34. von Lilienfeld-Toal M, Schneider A, Orlopp K, Hahn-Ast C, Glasmacher A, Stuber F (2006) Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. Support Care Cancer 14:1241-1245.